100 likes | 114 Views
Women are more prone to certain diseases, mostly related to menstrual disorders, depression, osteoporosis, obesity, and autoimmune diseases. Women's major health issues are related to the reproductive system that includes infertility, polycystic ovarian syndrome, menopause, and cancers such as breast cancer, cervical cancer, and urological disorders.
E N D
Opportunity Analysis and Industry Forecast, 2016-2023 Global Women's Health Diagnostics Market CAGR of 7.0% from 2018 to 2023 Global Opportunity Analysis and Industry Forecast, 2016-2023
WOMEN'S HEALTH DIAGNOSTICS MARKET Global Women's Health Diagnostics Market is projected to reach $21,501 million at a CAGR of 7.0% from 2017 to 2023. Gynecology is the main branch of medical science concerned with women's health problems. This includes the health related disorders, their screening and testing procedures. Women are highly prone to various cancers such as breast, cervical, and ovarian cancer. Other health issues include infertility, polycystic ovarian syndrome, menopause, depression, osteoporosis, and obesity. Rise in geriatric female population, increase in incidence of chronic and lifestyle disorders, demand for point of care diagnostic testing, and high adoption of diagnostics imaging procedures. Moreover, numerous government initiatives to promote women health awareness also drives the market growth. However, the market growth is limited by high cost of diagnostics tests and dearth of skilled professionals. Conversely, surge in demand for the development of miniature diagnostic devices, rise in healthcare infrastructure, and creative marketing initiatives by key vendors in emerging countries are expected to provide lucrative opportunities for the market expansion during the forecast period.
WOMEN'S HEALTH DIAGNOSTICS MARKET Factors such as rise in prevalence of various chronic lifestyle disorders in women, rise in female geriatric population who are more prone to several disorders, increase in adoption of point of care diagnosis, high demand for imaging and diagnosing centers, and support from government in promoting awareness about women related disorders. However, factors such as expensive imaging procedures and lack of skilled professionals restrains the market growth. Conversely, huge untapped market potential in the emerging countries, such as South Africa and India, and development of novel and advanced imaging procedures such as miniature devices are expected to provide lucrative opportunities to the market players.
WOMEN'S HEALTH DIAGNOSTICS MARKET Breast cancer testing is further segmented into hormone receptor test, immunohistochemistry test, and other tests. Cervical cancer testing is bifurcated into PAP smear and HPV test. Prenatal genetic screening and carrier testing include tests for cystic fibrosis and other diseases. The pregnancy and ovulation testing segment is further bifurcated into lab-based pregnancy and ovulation testing, and home-based pregnancy and ovulation testing. Depending on end user, it is categorized into hospitals and clinics, home care settings, diagnostic and imaging centers, and others. Based on region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
WOMEN'S HEALTH DIAGNOSTICS MARKET Segment Review Diagnostic tests segment accounted for the largest market share in 2018 and is expected to remain so throughout the forecast period. Diagnostic tests involve various tests related to women's health such as pregnancy and ovulation tests, breast cancer tests, ovarian cancer tests, and others. Factors such as high adoption of point-of-care diagnostics, rise in prevalence of women's health-related disorders, and growth in awareness about various tests drives the market for diagnostic tests. In addition, growth in healthcare expenditure, rise in awareness about malignant tumors, and availability of newer and advanced diagnostic systems further boost the market growth in near future. Download Full Sample Report: https://www.alliedmarketresearch.com/request-sample/4521
WOMEN'S HEALTH DIAGNOSTICS MARKET • Key findings of the Women's Health Diagnostics Market: • Diagnostic tests segment accounted for around 55.1% share of the global women's health diagnostics market in 2016 • Diagnostic devices segment is expected to grow at a CAGR of 6.5% from 2017 to 2023. • Hospitals and clinics segment accounted for around 49.8% share of the global women's health diagnostics market in 2016 • North America accounted for around 33.7% share of the global women's health diagnostics market in 2016 • Asia-Pacific is expected to grow at the highest CAGR of 8.1% from 2017 to 2023 • Do Purchase and Enquiry This Report: https://www.alliedmarketresearch.com/purchase-enquiry/4521
WOMEN'S HEALTH DIAGNOSTICS MARKET • Women's Health Diagnostics Market Key Segments: • By Type • Diagnostic Devices • Diagnostic Tests • Breast Cancer Testing • Hormone Receptor Test • Immunohistochemistry (IHC) Test • Other Tests • Cervical Cancer Testing • PAP Smear (PAP) Test • HPV Test • Prenatal Genetic Screening and Carrier Testing • Cystic Fibrosis • Other Diseases • Pregnancy and Ovulation Testing • Lab-based Pregnancy and Ovulation Testing • Home Based Pregnancy and Ovulation Testing • Ovarian Cancer Testing • Accessories and Consumables • By End User • Hospitals and Clinics • Home Care Settings • Diagnostic and Imaging Centers • Others
WOMEN'S HEALTH DIAGNOSTICS MARKET By Region North America Europe Asia-Pacific LAMEA
WOMEN'S HEALTH DIAGNOSTICS MARKET Contact:Shriram Dighe5933 NE Win Sivers Drive#205, Portland, OR 97220United StatesToll Free: +1-800-792-5285UK: +44-845-528-1300Hong Kong: +852-301-84916India (Pune): +91-20-66346060Fax: +1⟨855⟩550-5975help@alliedmarketresearch.com Web: https://www.alliedmarketresearch.com
WOMEN'S HEALTH DIAGNOSTICS MARKET Thank You! For More Details Visit us at https://www.alliedmarketresearch.com Follow Us On